We suggest that altered expression of cis-genes affected by underlying copy number aberrations may increase the activity of this pathwayDrugs that target the mTOR pathway have shown interesting results in other cancer types [52], which highlight its clinical importance. This evidence concerns the gene MTOR and cancer.